tiprankstipranks
Catalyst Pharmaceutical Partners (CPRX)
NASDAQ:CPRX
US Market
CPRX
Catalyst Pharma
RESEARCH TOOLSreports
Want to see CPRX full AI Analyst Report?

Catalyst Pharma (CPRX) Ratios

2,544 Followers

Catalyst Pharma Ratios

CPRX's free cash flow for Q1 2026 was $0.84. For the 2026 fiscal year, CPRX's free cash flow was decreased by $ and operating cash flow was $0.49. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 7.10 6.08 5.17 2.88 5.57
Quick Ratio
 6.84 5.82 5.01 2.68 5.45
Cash Ratio
 5.71 4.82 4.29 1.81 5.18
Solvency Ratio
 1.92 1.65 1.63 1.27 1.12
Operating Cash Flow Ratio
 1.57 1.42 1.99 1.89 2.02
Short-Term Operating Cash Flow Coverage
 466.85 477.51 0.00 0.00 0.00
Net Current Asset Value
$ 805.48M$ 741.49M$ 499.83M$ 137.10M$ 245.60M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.13 1.16 1.17 1.21 1.25
Debt Service Coverage Ratio
 534.83 518.22 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 0.02 0.02 0.03 0.03 0.04
Net Debt to EBITDA
 -2.40 -2.39 -2.21 -1.12 -2.86
Profitability Margins
Gross Profit Margin
82.32%85.19%86.00%86.95%83.94%
EBIT Margin
46.13%43.77%39.68%21.80%47.54%
EBITDA Margin
52.54%50.20%47.36%30.06%48.12%
Operating Profit Margin
44.83%43.77%39.68%21.80%47.54%
Pretax Profit Margin
49.66%48.14%43.98%23.73%48.89%
Net Profit Margin
37.08%36.39%33.33%17.93%38.79%
Continuous Operations Profit Margin
37.08%36.39%33.33%17.93%38.79%
Net Income Per EBT
74.66%75.60%75.78%75.56%79.34%
EBT Per EBIT
110.77%109.98%110.83%108.87%102.83%
Return on Assets (ROA)
19.29%19.36%19.25%15.19%22.12%
Return on Equity (ROE)
23.65%22.46%22.52%18.41%27.65%
Return on Capital Employed (ROCE)
26.36%26.86%26.70%22.03%32.02%
Return on Invested Capital (ROIC)
19.67%20.30%20.22%16.63%25.38%
Return on Tangible Assets
21.58%21.98%23.59%25.87%24.21%
Earnings Yield
5.79%7.51%6.63%4.00%4.32%
Efficiency Ratios
Receivables Turnover
 4.55 4.59 7.51 7.44 19.85
Payables Turnover
 14.76 7.79 4.15 3.51 8.65
Inventory Turnover
 3.02 2.35 3.52 3.32 5.05
Fixed Asset Turnover
 209.31 198.18 137.20 107.54 59.22
Asset Turnover
 0.52 0.53 0.58 0.85 0.57
Working Capital Turnover Ratio
 0.77 0.94 1.52 1.96 0.96
Cash Conversion Cycle
 176.37 188.10 64.24 55.01 48.42
Days of Sales Outstanding
 80.28 79.49 48.61 49.05 18.39
Days of Inventory Outstanding
 120.82 155.47 103.60 109.88 72.22
Days of Payables Outstanding
 24.74 46.86 87.97 103.92 42.19
Operating Cycle
 201.11 234.96 152.21 158.93 90.61
Cash Flow Ratios
Operating Cash Flow Per Share
 1.70 1.71 2.02 1.35 1.12
Free Cash Flow Per Share
 1.70 1.71 2.02 0.58 1.12
CapEx Per Share
 <0.01 <0.01 <0.01 0.77 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 0.43 1.00
Dividend Paid and CapEx Coverage Ratio
 2.45K 3.60K 431.31 1.76 4.00K
Capital Expenditure Coverage Ratio
 2.45K 3.60K 431.31 1.76 4.00K
Operating Cash Flow Coverage Ratio
 77.66 74.87 75.22 40.37 29.80
Operating Cash Flow to Sales Ratio
 0.35 0.35 0.49 0.36 0.54
Free Cash Flow Yield
5.44%7.31%9.68%3.46%6.03%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 17.26 13.32 15.08 25.02 23.14
Price-to-Sales (P/S) Ratio
 6.41 4.85 5.03 4.49 8.98
Price-to-Book (P/B) Ratio
 3.77 2.99 3.40 4.61 6.40
Price-to-Free Cash Flow (P/FCF) Ratio
 18.38 13.68 10.33 28.88 16.57
Price-to-Operating Cash Flow Ratio
 18.35 13.68 10.31 12.44 16.57
Price-to-Earnings Growth (PEG) Ratio
 2.05 0.50 0.14 -1.54 0.21
Price-to-Fair Value
 3.77 2.99 3.40 4.61 6.40
Enterprise Value Multiple
 9.79 7.26 8.41 13.81 15.80
Enterprise Value
 3.07B 2.15B 1.96B 1.65B 1.63B
EV to EBITDA
 9.79 7.26 8.41 13.81 15.80
EV to Sales
 5.14 3.65 3.98 4.15 7.60
EV to Free Cash Flow
 14.76 10.30 8.18 26.72 14.03
EV to Operating Cash Flow
 14.75 10.29 8.16 11.51 14.03
Tangible Book Value Per Share
 7.29 6.73 4.82 1.82 2.59
Shareholders’ Equity Per Share
 8.28 7.80 6.14 3.65 2.91
Tax and Other Ratios
Effective Tax Rate
 0.25 0.24 0.24 0.24 0.21
Revenue Per Share
 4.88 4.82 4.15 3.75 2.07
Net Income Per Share
 1.81 1.75 1.38 0.67 0.80
Tax Burden
 0.75 0.76 0.76 0.76 0.79
Interest Burden
 1.08 1.10 1.11 1.09 1.03
Research & Development to Revenue
 0.02 0.02 0.03 0.23 0.09
SG&A to Revenue
 0.33 0.33 0.36 0.12 0.25
Stock-Based Compensation to Revenue
 0.03 0.04 0.05 0.04 0.04
Income Quality
 0.94 0.97 1.46 2.01 1.40
Currency in USD